The Effect of Dexlansoprazole on Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis evaluated the efficacy of dexlansoprazole (a proton pump inhibitor—PPI) in resolving heartburn, reflux, and other symptoms and complications resulting from gastroesophageal reflux disease (GERD). The study followed PRISMA 2020 and was registered in PROSPERO (...
Main Authors: | Gabriel Pereira Nunes, Thayná Cerqueira Silveira, João Vítor Silveira Marciano, Alexandre Henrique dos Reis-Prado, Tulio Morandin Ferrisse, Evandro Barbosa dos Anjos, Maria Helena Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/2/1247 |
Similar Items
-
GASTROESOPHAGEAL REFLUX: NEW THERAPEUTIC PROSPECTS
by: S. S. Kardasheva, et al.
Published: (2017-07-01) -
Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2024-03-01) -
The strategy for choosing a new-generation proton pump inhibitor dexlansoprazole in the treatment of gastroesophageal reflux disease
by: N. V. Topchiy, et al.
Published: (2018-04-01) -
Correlation between cough and gastroesophageal reflux in children
by: A. V. Burlutskaya, et al.
Published: (2022-09-01) -
GASTROESOPHAGEAL REFLUX DISEASE’S IMPACT ON CHILDREN’S HEALTH
by: Ana Maria Laura Buga, et al.
Published: (2023-03-01)